Arch Biopartners Inc Total Assets

Latest as of March 2026: CA$463.16K CAD ≈ $335.04K USD

Arch Biopartners Inc total assets. Based on the latest financial reports, Arch Biopartners Inc (ARCH) holds total assets worth CA$463.16K CAD (≈ $335.04K USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see Arch Biopartners Inc stock valuation for the company's overall valuation and market capitalisation.

Total Assets of Arch Biopartners Inc (1997–2025)

Total assets of Arch Biopartners Inc from 1997 to 2025. This chart illustrates how Arch Biopartners Inc's total assets have evolved over time, based on quarterly financial data. See ARCH live share price for real-time trading data and today's change.

Arch Biopartners Inc - Asset Composition Analysis

Arch Biopartners Inc Total Assets Breakdown (September 2025)

Arch Biopartners Inc total assets breakdown as of September 2025. Arch Biopartners Inc's total assets of CA$463.16K consist of 100.0% current assets and 0.0% non-current assets.

Asset Category	Amount (CAD)	% of Total Assets
Cash & Equivalents	CA$0.00	2.0%
Accounts Receivable	CA$0.00	0.0%
Inventory	CA$0.00	0.0%
Property, Plant & Equipment	CA$0.00	0.0%
Intangible Assets	CA$0.00	0.0%
Goodwill	CA$0.00	0.0%

Asset Composition Trend (1997–2025)

This chart illustrates how Arch Biopartners Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore ARCH current assets to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Arch Biopartners Inc's current assets represent 100.0% of total assets in 2025, an increase from 3.5% in 1997.
Cash Position: Cash and equivalents constituted 2.0% of total assets in 2025, up from 1.3% in 1997.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 11.0% in 1997.
Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.

Arch Biopartners Inc Competitors by Total Assets

Key competitors of Arch Biopartners Inc based on total assets are shown below.

Company	Country	Total Assets
CSL Ltd AU:CSL	Australia	AU$39.54 Billion
Genmab A/S CO:GMAB	Denmark	Dkr7.02 Billion
Biomarin Pharmaceutical Inc NASDAQ:BMRN	USA	$11.72 Billion
Xizang Haisco Pharmaceutical Group Co Ltd SHE:002653	China	CN¥7.88 Billion
Abivax SA American Depositary Shares NASDAQ:ABVX	USA	$462.21 Million
Bachem Holding AG SW:BANB	Switzerland	CHF2.11 Billion
Viking Therapeutics Inc NASDAQ:VKTX	USA	$521.90 Million
SOLENO THERAPEUT. DL-001 F:6XC	Germany	€563.83 Million

Arch Biopartners Inc - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	0.11	0.13	0.65
Quick Ratio	0.11	0.13	0.65
Cash Ratio	0.00	0.00	0.00
Working Capital	CA$-3.64 Million	CA$-3.77 Million	CA$-1.43 Million

Arch Biopartners Inc - Advanced Valuation Insights

This section examines the relationship between Arch Biopartners Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	6211.54
Latest Market Cap to Assets Ratio	390.20
Asset Growth Rate (YoY)	-88.8%
Total Assets	CA$104.53K
Market Capitalization	$40.79 Million USD

Valuation Analysis

Premium Asset Valuation: The market values Arch Biopartners Inc's assets at a significant premium (390.20x), suggesting investors see substantial growth potential or unique competitive advantages.

Significant Asset Reduction: Arch Biopartners Inc's assets decreased by 88.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Arch Biopartners Inc (1997–2025)

The table below shows the annual total assets of Arch Biopartners Inc from 1997 to 2025.

Year	Total Assets	Change
2025-09-30	CA$104.53K ≈ $75.62K	-88.83%
2024-09-30	CA$935.62K ≈ $676.81K	-20.11%
2023-09-30	CA$1.17 Million ≈ $847.21K	+88.40%
2022-09-30	CA$621.64K ≈ $449.69K	-76.70%
2021-09-30	CA$2.67 Million ≈ $1.93 Million	+259.94%
2020-09-30	CA$741.30K ≈ $536.25K	+30.52%
2019-09-30	CA$567.98K ≈ $410.87K	-15.57%
2018-09-30	CA$672.69K ≈ $486.62K	+890.16%
2017-09-30	CA$67.94K ≈ $49.15K	-70.08%
2016-09-30	CA$227.03K ≈ $164.23K	-65.05%
2015-09-30	CA$649.50K ≈ $469.84K	+60.06%
2014-09-30	CA$405.79K ≈ $293.54K	+1001.91%
2013-09-30	CA$36.83K ≈ $26.64K	-60.75%
2012-09-30	CA$93.81K ≈ $67.86K	-57.75%
2011-09-30	CA$222.04K ≈ $160.62K	-58.52%
2010-09-30	CA$535.28K ≈ $387.22K	+33355.19%
2009-09-30	CA$1.60K ≈ $1.16K	-99.80%
2008-09-30	CA$797.32K ≈ $576.77K	-16.98%
2007-09-30	CA$960.41K ≈ $694.75K	+0.74%
2006-09-30	CA$953.38K ≈ $689.66K	-17.63%
2005-09-30	CA$1.16 Million ≈ $837.31K	-15.87%
2004-09-30	CA$1.38 Million ≈ $995.26K	-16.02%
2003-09-30	CA$1.64 Million ≈ $1.19 Million	+2668.41%
2002-09-30	CA$59.18K ≈ $42.81K	-16.12%
2001-09-30	CA$70.56K ≈ $51.04K	-97.02%
2000-09-30	CA$2.37 Million ≈ $1.71 Million	+87.01%
1999-09-30	CA$1.26 Million ≈ $914.95K	+575.79%
1998-09-30	CA$187.16K ≈ $135.39K	-47.71%
1997-09-30	CA$357.96K ≈ $258.94K	--

About Arch Biopartners Inc

V:ARCH Canada Biotechnology

Market Cap

$40.79 Million

CA$56.38 Million CAD

Market Cap Rank

#22463 Global

#793 in Canada

Share Price

CA$0.83

Change (1 day)

+2.47%

52-Week Range

CA$0.41 - CA$1.45

All Time High

CA$5.00